Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.
The Opportunity:
Revolution Medicines is seeking a Director, Revenue Accounting and Finance to provide leadership across revenue accounting, gross to net accounting and forecasting, and related commercial finance activities as the company continues to scale its commercial operations.
Reporting to the Senior Director, Revenue Accounting and Finance, this role will lead critical revenue and gross to net processes, including financial close, forecasting, controls, government pricing coordination, analytics, and global revenue reporting. The Director will balance strong operational execution with longer term process development, helping establish scalable methodologies, controls, and reporting capabilities to support the company’s continued commercial growth.
This individual will serve as a senior Finance partner to Commercial, Market Access, Analytics & Insights, Corporate Accounting, FP&A, and regional Finance teams. The ideal candidate will bring deep pharmaceutical revenue and gross to net expertise, strong technical accounting judgment, and the ability to lead complex cross functional initiatives, influence business decisions, and translate commercial and market dynamics into actionable financial insights.
Key Responsibilities:
Lead and oversee monthly product revenue and gross to net close activities, including the calculation, review, and monitoring of accruals and reserve balances for prompt pay discounts, copay and patient assistance programs, returns, Medicaid, Medicare Part D, 340B, VA/DoD, and other forms of variable consideration.
Provide leadership and oversight of revenue and GTN accounting processes, including journal entries, account reconciliations, flux analyses, reserve rollforwards, close schedules, and supporting documentation, ensuring accuracy, timeliness, and appropriate review.
Own and continuously strengthen the control environment for revenue and GTN processes, establishing scalable policies, procedures, and internal controls that support SOX compliance, audit readiness, and continued commercial growth.
Lead the development and evolution of RevMed’s GTN forecasting models and methodologies for budget, forecast, long range planning, and scenario analysis, ensuring assumptions and methodologies appropriately reflect changing business and market dynamics.
Serve as a senior Finance partner to Commercial and Market Access, providing financial leadership on GTN assumptions, forecast development, performance trends, pricing and contracting considerations, and the financial implications of evolving access strategies.
Lead partnership with Analytics & Insights to incorporate demand, patient, payer, and market data into GTN forecasts and analyses and translate emerging trends into actionable insights for Finance and business leadership.
Drive the development of analytics and management reporting that provide visibility into gross sales, discounts, reserve adequacy, forecast accuracy, and key risks and opportunities, and use these insights to inform senior leadership decision making.
Provide oversight of the external government pricing consultant relationship, including data submissions, review of government pricing calculations and outputs, resolution of complex issues, and support for accuracy and compliance across Medicaid, Medicare Part D, 340B, VA/FSS, and other applicable government programs.
Drive adoption of approved AI enabled tools, automation, and advanced analytics to scale revenue accounting, GTN forecasting, reconciliations, reporting, and close processes while maintaining appropriate governance, internal controls, auditability, and compliance with company policies.
Partner closely with the Senior Director, Revenue Accounting and Finance and the Vice President, Finance and Corporate Accounting on strategic initiatives, complex cross functional matters, SEC reporting disclosures, and significant revenue and GTN accounting or forecasting decisions.
Lead HQ coordination for global revenue and reporting, partnering with regional Finance and Accounting teams to establish consistent revenue inputs, forecasting methodologies, key assumptions, controls, variance analysis, and consolidation ready reporting across markets.
Required Skills, Experience and Education:
Bachelor’s degree in Accounting, Finance, Economics, or a related field.
10+ years of progressive accounting, finance, or related experience, including significant revenue accounting and gross to net experience within the pharmaceutical or biotechnology industry.
Deep expertise in pharmaceutical revenue accounting, gross to net accounting and forecasting, including application of U.S. GAAP and ASC 606 to commercial revenue arrangements.
Strong understanding of pharmaceutical GTN drivers, including rebates, chargebacks, discounts, returns, copay and patient assistance programs, government programs, distributor fees, and other forms of variable consideration.
Demonstrated experience developing and evolving GTN forecasting methodologies, analyzing forecast versus actual performance, and translating business and market dynamics into financial assumptions and recommendations.
Experience strengthening accounting processes, policies, and internal controls in a public company environment subject to SOX, SEC, and U.S. GAAP requirements.
Demonstrated ability to lead complex, cross functional initiatives and influence decisions across Commercial, Market Access, Analytics & Insights, FP&A, Accounting, and senior leadership.
Strong strategic and analytical judgment with the ability to identify complex issues, develop practical solutions, and balance short term execution with longer term scalability.
Experience working with external consultants and commercial partners and holding third parties accountable for accurate and timely deliverables.
Strong executive communication skills with the ability to clearly communicate complex financial matters, business risks, recommendations, and insights to senior leaders and non Finance stakeholders.
Demonstrated interest in and experience using AI, automation, or advanced analytics to improve Finance processes and decision making.
Advanced analytical skills and proficiency in Microsoft Excel, Word, and PowerPoint.
Preferred Skills:
CPA or MBA preferred.
Experience supporting a first commercial product launch or scaling Finance infrastructure within an early commercial stage pharmaceutical or biotechnology company.
Experience operating across global or multi regional commercial organizations and coordinating revenue reporting and forecasting across regional Finance teams.
Experience overseeing third party government pricing, GTN, contract analytics, or related commercial Finance vendors.
Experience with SEC reporting and revenue related financial statement disclosures.
Experience implementing or improving revenue accounting, GTN forecasting, analytics, reporting, or automation tools.
#LI-TS1 #LI-Hybrid
The base pay salary range for this full-time position for candidates working onsite at our headquarters in Redwood City, CA is listed below. The range displayed on each job posting is intended to be the base pay salary range for an individual working onsite in Redwood City and will be adjusted for the local market a candidate is based in. Our base pay salary ranges are determined by role, level, and location. Individual base pay salary is determined by multiple factors, including job-related skills, experience, market dynamics, and relevant education or training.
Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Revolution Medicines is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital status, medical condition, and veteran status.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact [email protected].
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to [email protected] so we can share these impersonations with our IT team for tracking and awareness.
Similar Jobs
What you need to know about the Colorado Tech Scene
Key Facts About Colorado Tech
- Number of Tech Workers: 260,000; 8.5% of overall workforce (2024 CompTIA survey)
- Major Tech Employers: Lockheed Martin, Century Link, Comcast, BAE Systems, Level 3
- Key Industries: Software, artificial intelligence, aerospace, e-commerce, fintech, healthtech
- Funding Landscape: $4.9 billion in VC funding in 2024 (Pitchbook)
- Notable Investors: Access Venture Partners, Ridgeline Ventures, Techstars, Blackhorn Ventures
- Research Centers and Universities: Colorado School of Mines, University of Colorado Boulder, University of Denver, Colorado State University, Mesa Laboratory, Space Science Institute, National Center for Atmospheric Research, National Renewable Energy Laboratory, Gottlieb Institute

.png)